Insights: Stories
Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’ serious and complex medical challenges.
These are the stories of the people throughout that journey — from the laboratorians conducting tests and delivering results, to the physicians guiding diagnosis and treatment, to the patients worldwide who need answers.
Most recent posts
Supported by Mayo Clinic’s holistic, precision medicine approach, which included advanced genetic insights, access to an emerging therapy, and tailored treatment monitoring, Giana Urse gained the confidence and clarity she needed to pursue her dream of becoming a dog trainer.
This week’s research roundup features a study on distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
This week’s research roundup features a study on myocardial histopathology in patients with obstructive hypertrophic cardiomyopathy.
Top highlights include: Additional insight for when the vaccine will be available for children, Mayo Clinic aims to offer more walk-in COVID-19 vaccine clinics in Rochester, and how preventive screening leads to an early diagnosis of treatable breast cancer.
As an experienced laboratory professional, Peter Wegwerth was well-suited to pivot from his work in Mayo Clinic's Biochemical Genetics Laboratory to redeployment in a COVID-19 testing lab when the pandemic hit in 2020.
This week’s research roundup features a study on positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing.
Top highlights include: New CDC guidance for vaccinated adults, the importance of the second dose, and who's at higher risk for serious symptoms.
The Office of Decedent Affairs plays a key role in Mayo Clinic’s mission as its staff guide families through the logistics and complexities of a loved one’s death with skill and empathy.
This week’s research roundup features a study on how the CLL-international prognostic index (CLL-IPI) predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Top highlights include: J&J COVID-19 vaccine pause ends, combating allergies during the pandemic, and researchers question effectiveness of mRNA COVID-19 vaccines for solid organ transplant patients.
Kae Essler’s behind-the-scenes role managing Mayo Clinic Laboratories’ Client Conversion team may not be highly visible, but her group’s work is crucial to ensuring an easy transition for clients and setting the stage for a productive collaboration going forward.
This week’s research roundup features a study on protocadherin 7-associated membranous nephropathy.